Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2018
Dec. 31, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 32,959,000 $ 51,101,000
Other investments 26,997,000 3,054,000
Royalty receivables, net 448,000 575,000
Prepaid taxes 125,000
Other current assets 44,000 83,000
Total Current Assets 60,448,000 54,938,000
OTHER ASSETS:    
Deferred tax assets 168,000 168,000
Patents, net of accumulated amortization 2,083,000 2,169,000
Security deposits 19,000 19,000
Total Other Assets 2,270,000 2,356,000
TOTAL ASSETS 62,718,000 57,294,000
CURRENT LIABILITIES:    
Accounts payable 234,000 244,000
Income taxes payable 1,164,000
Accrued contingency fees and related costs 737,000 1,780,000
Accrued payroll 58,000 709,000
Other accrued expenses 191,000 149,000
TOTAL LIABILITIES 2,384,000 2,882,000
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at June 30, 2018 and December 31, 2017, respectively
Common stock, $0.01 par value; authorized 50,000,000 shares; 23,633,229 and 23,843,915 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively 236,000 238,000
Additional paid-in capital 64,916,000 64,435,000
Accumulated deficit (4,742,000) (10,219,000)
Accumulated other comprehensive loss (76,000) (42,000)
TOTAL STOCKHOLDERS' EQUITY 60,334,000 54,412,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 62,718,000 $ 57,294,000